Sort by
Refine Your Search
-
Listed
-
Category
-
Country
-
Program
-
Field
-
the Guilliams and the Saelens team. Research Project In this research project you will apply in vivo CRISPR screens to study the functional specialization of liver macrophages. This project is supported by an ERC
-
students, and generate reports or publications. Qualifications Required Qualifications: -PhD (must have defended thesis) -NK cell biology and gene editing. -Experience with CRISPR editing also required
-
Our lab has developed novel CRISPR-based tools for functional genomics in the globally important pathogen, Mycobacterium tuberculosis. At Rockefeller, you will join a dynamic research team to
-
extensive use of advanced molecular cell biology methods, as well as proteomic and genomic methods. Home page: https://www.ous-research.no/wesche More about the position Precision medicine is the new paradigm
-
minimum of 12 months Appointment Start Date: Early/mid 2026 Group or Departmental Website: https://evodesign.org/ (link is external) How to Submit Application Materials: Please directly contact us at
-
, immunoprecipitation (IP), cell culture, immunofluorescence (IF), qRT-PCR, Western blotting, and CRISPR/Cas9 gene editing. Scientific Proficiency: A proven track record of independent experimental design
-
Using CRISPR-Cas9 to rewire photosynthesis in plants and algae School of Biosciences PhD Research Project Self Funded Prof Matt Johnson, Dr Andy Hitchcock Application Deadline: Applications
-
, including use of CRISPR, is strongly desired. In this role, you will: Plan approach to experiments in support of research projects in lab and/or field based on knowledge of scientific theory. Independently
-
CRISPR-based gene editing in the salmon louse. The small size of its oocytes poses a challenge for the delivery of the gene editing compounds. Therefore, CRISPR is not available in this species, yet. To
-
fundamental and translational aspects of infectious disease (germfree/gnotobiotic animal facility, organoid cultures, T-cell engineering via CRISPR/Cas9 technology, in vivo imaging, animal models, microbiome